MedTrace Logo

In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions

NCT03371641 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-06

No results posted yet for this study

Summary

This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.

Conditions

  • Fetal Alcohol Syndrome

Interventions

BEHAVIORAL

ASQ parental questionnaire

ASQ parental questionnaire

BEHAVIORAL

Development scales

WPPSI - IV and NEPSY development scales

BEHAVIORAL

Scale of Conners

Scale of Conners

BEHAVIORAL

SCQ Questionnaire

SCQ questionnaire

PROCEDURE

Blood sample (mother)

Blood sample (mother) before delivery

PROCEDURE

Cord blood sample

Cord blood sample after delivery

PROCEDURE

Placenta sample

Placenta sample

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-27
Primary Completion
2026-03-27
Completion
2026-03-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03371641 on ClinicalTrials.gov